TRANYLCYPROMINE SULFATE

TRANYLCYPROMINE SULFATE was reported 804 times

TRANYLCYPROMINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALE PATTERN BALDNESS 1 0.1667
1 LYMPHATIC INSUFFICIENCY 1 0.1250
2 CAROTID PULSE 1 0.1250
3 TYRAMINE REACTION 1 0.0909
4 DIET NONCOMPLIANCE 27 0.0734
5 ELECTRONIC CIGARETTE USER 1 0.0667
6 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 30 0.0601
7 DYSSOMNIA 7 0.0365
8 ULTRASOUND BREAST ABNORMAL 1 0.0333
9 JAW CLICKING 7 0.0329
10 ELECTROCONVULSIVE THERAPY 2 0.0183
11 MISCARRIAGE OF PARTNER 1 0.0182
12 METANEPHRINE URINE INCREASED 1 0.0164
13 FOOD INTERACTION 27 0.0153
14 TANDEM GAIT TEST ABNORMAL 1 0.0139
15 SKIN LESION EXCISION 1 0.0125
16 BLOOD CARBON MONOXIDE INCREASED 1 0.0123
17 SPOUSAL ABUSE 1 0.0120
18 ANAL FISSURE HAEMORRHAGE 2 0.0109
19 BIOPSY BREAST ABNORMAL 1 0.0105
20 POTENTIATING DRUG INTERACTION 35 0.0104
21 ABSCESS DRAINAGE 9 0.0104
22 INSULIN C-PEPTIDE DECREASED 1 0.0097
23 PERONEAL NERVE INJURY 1 0.0088
24 CEREBROVASCULAR SPASM 1 0.0076
25 SKIN CHAPPED 3 0.0074
26 EYE REDNESS 2 0.0071
27 LESION EXCISION 1 0.0070
28 POOR DENTAL CONDITION 2 0.0068
29 BLOOD LACTIC ACID DECREASED 1 0.0058
30 POST PROCEDURAL CELLULITIS 1 0.0055
31 HYPERTENSIVE CRISIS 60 0.0054
32 NEUROTRANSMITTER LEVEL ALTERED 1 0.0053
33 SUPINE HYPERTENSION 1 0.0053
34 UNEXPECTED THERAPEUTIC DRUG EFFECT 1 0.0052
35 ANTIDEPRESSANT DISCONTINUATION SYNDROME 1 0.0048
36 PERIPHERAL NERVE OPERATION 1 0.0046
37 BULIMIA NERVOSA 2 0.0046
38 MONOCYTE COUNT ABNORMAL 1 0.0045
39 ILLUSION 7 0.0042
40 DYSCALCULIA 1 0.0040
41 INTUBATION 1 0.0040
42 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 1 0.0040
43 SKIN DESQUAMATION 1 0.0040
44 THUNDERCLAP HEADACHE 1 0.0038
45 VICTIM OF ABUSE 1 0.0037
46 LABILE HYPERTENSION 1 0.0036
47 CONVERSION DISORDER 7 0.0036
48 VASCULAR ENCEPHALOPATHY 1 0.0035
49 TONGUE MOVEMENT DISTURBANCE 3 0.0035
50 POUCHITIS 3 0.0035
51 AGITATED DEPRESSION 1 0.0035
52 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
53 INTRUSIVE THOUGHTS 4 0.0034
54 FALLOPIAN TUBE DISORDER 1 0.0034
55 ASPIRATION BRONCHIAL 1 0.0034
56 AKINESIA 7 0.0034
57 DRUG DOSE TITRATION NOT PERFORMED 6 0.0033
58 ANAL HAEMORRHAGE 9 0.0032
59 ACANTHOSIS 1 0.0030
60 YAWNING 8 0.0030
61 CHEST WALL PAIN 1 0.0030
62 OCULAR MYASTHENIA 1 0.0029
63 COUNTERFEIT DRUG ADMINISTERED 1 0.0029
64 SOCIAL PHOBIA 1 0.0029
65 MENTAL FATIGUE 4 0.0027
66 HYPERREFLEXIA 9 0.0026
67 OPISTHOTONUS 2 0.0025
68 FISTULA DISCHARGE 3 0.0024
69 PHLEBITIS SUPERFICIAL 1 0.0024
70 APPARENT LIFE THREATENING EVENT 1 0.0024
71 MOUTH BREATHING 1 0.0023
72 VULVOVAGINAL RASH 1 0.0023
73 MUSCLE CRAMP 4 0.0023
74 CONTRAINDICATED PRODUCT ADMINISTERED 68 0.0022
75 CLONUS 6 0.0022
76 HYPOMANIA 8 0.0022
77 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
78 BASEDOW'S DISEASE 1 0.0021
79 TRANSMISSION OF DRUG VIA SEMEN 1 0.0021
80 ANAL FISTULA 11 0.0021
81 HYPERTHERMIA MALIGNANT 3 0.0020
82 SENSORIMOTOR DISORDER 1 0.0020
83 MYOGLOBINURIA 1 0.0019
84 SEROTONIN SYNDROME 36 0.0019
85 GALLBLADDER ENLARGEMENT 2 0.0019
86 THROMBOCYTHAEMIA 1 0.0018
87 BRAIN SCAN ABNORMAL 1 0.0018
88 EJACULATION DELAYED 1 0.0018
89 LIFE SUPPORT 1 0.0018
90 EYE MOVEMENT DISORDER 12 0.0018
91 COLON INJURY 1 0.0017
92 SLEEP WALKING 1 0.0017
93 NERVE ROOT COMPRESSION 1 0.0017
94 HYPERTENSIVE EMERGENCY 2 0.0017
95 ADRENAL ADENOMA 1 0.0017
96 BRUXISM 9 0.0017
97 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
98 NEURODEGENERATIVE DISORDER 1 0.0016
99 GASTROENTERITIS NOROVIRUS 2 0.0015
100 ANION GAP INCREASED 2 0.0015
101 THROAT LESION 1 0.0015
102 ARTHROSCOPY 1 0.0015
103 CATAPLEXY 2 0.0014
104 MYOFASCIAL PAIN SYNDROME 1 0.0014
105 PROCTALGIA 9 0.0014
106 CALCULUS URETERIC 1 0.0014
107 MICTURITION FREQUENCY DECREASED 1 0.0013
108 DIAPHRAGMATIC DISORDER 1 0.0013
109 BLOOD ALCOHOL INCREASED 1 0.0013
110 RETROGRADE EJACULATION 1 0.0013
111 MULTIPLE DRUG OVERDOSE INTENTIONAL 4 0.0012
112 FEAR OF FALLING 1 0.0012
113 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
114 PSYCHIATRIC SYMPTOM 9 0.0012
115 DYSBIOSIS 1 0.0012
116 GAZE PALSY 2 0.0012
117 ALLERGIC SINUSITIS 1 0.0012
118 CHOREA 2 0.0012
119 VASOCONSTRICTION 1 0.0011
120 VASCULAR DEMENTIA 1 0.0011
121 LARGE FOR DATES BABY 1 0.0011
122 ALCOHOL POISONING 3 0.0011
123 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
124 VASOSPASM 1 0.0011
125 COLOUR BLINDNESS 1 0.0011
126 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
127 DENTAL CARE 2 0.0011
128 INTERCEPTED MEDICATION ERROR 5 0.0011
129 SLEEP-RELATED EATING DISORDER 1 0.0011
130 HYPOREFLEXIA 2 0.0010
131 ALCOHOL INTERACTION 2 0.0010
132 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 2 0.0010
133 DROWNING 1 0.0010
134 HOMICIDAL IDEATION 4 0.0010
135 PRODUCT COATING ISSUE 1 0.0010
136 FEEDING DISORDER NEONATAL 1 0.0010
137 WALKING DISABILITY 2 0.0010
138 HYPOPERFUSION 1 0.0010
139 TONGUE DISCOMFORT 4 0.0009
140 OCULOGYRIC CRISIS 2 0.0009
141 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
142 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
143 AORTIC DILATATION 1 0.0009
144 MOANING 1 0.0009
145 PUPILS UNEQUAL 1 0.0009
146 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
147 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
148 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
149 URINARY HESITATION 2 0.0008
150 HAEMATOCRIT ABNORMAL 1 0.0008
151 ALLERGY TO CHEMICALS 1 0.0008
152 LEFT ATRIAL DILATATION 1 0.0008
153 LACTOSE INTOLERANCE 2 0.0008
154 PRESCRIBED OVERDOSE 15 0.0008
155 FEELINGS OF WORTHLESSNESS 1 0.0008
156 DEVICE MISUSE 1 0.0008
157 NYSTAGMUS 4 0.0008
158 INTESTINAL DILATATION 1 0.0007
159 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
160 BLOOD PHOSPHORUS INCREASED 2 0.0007
161 PREMENSTRUAL SYNDROME 1 0.0007
162 RENAL ARTERY STENOSIS 1 0.0007
163 SOCIAL PROBLEM 3 0.0007
164 APPLICATION SITE INFLAMMATION 1 0.0007
165 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 3 0.0007
166 COORDINATION ABNORMAL 10 0.0007
167 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
168 GLUTEN SENSITIVITY 1 0.0007
169 SMEAR CERVIX ABNORMAL 1 0.0007
170 GENITAL RASH 1 0.0007
171 HYPERTONIA 4 0.0007
172 NAIL INFECTION 1 0.0007
173 TEARFULNESS 3 0.0007
174 VISUAL DISTURBANCE 4 0.0007
175 ABSCESS 11 0.0007
176 JUDGEMENT IMPAIRED 1 0.0007
177 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
178 APATHY 10 0.0007
179 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
180 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
181 APRAXIA 1 0.0007
182 MYOCLONIC EPILEPSY 1 0.0007
183 DAYDREAMING 1 0.0006
184 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
185 VIOLENCE-RELATED SYMPTOM 1 0.0006
186 HYPOTONIA NEONATAL 1 0.0006
187 FAECAL CALPROTECTIN INCREASED 2 0.0006
188 INAPPROPRIATE AFFECT 1 0.0006
189 DISINHIBITION 1 0.0006
190 RESUSCITATION 1 0.0006
191 ARTHROPOD STING 1 0.0006
192 THERAPEUTIC AGENT TOXICITY 2 0.0006
193 GASTRIC DILATATION 1 0.0006
194 AKATHISIA 8 0.0006
195 BLOOD PH DECREASED 1 0.0006
196 TACHYPHRENIA 2 0.0006
197 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
198 ORTHOSTATIC HYPOTENSION 10 0.0006
199 DYSTONIA 11 0.0006
200 FEAR OF DISEASE 1 0.0006
201 VENOUS OCCLUSION 1 0.0005
202 HOMICIDE 1 0.0005
203 HYPERACUSIS 2 0.0005
204 IMPATIENCE 1 0.0005
205 SNORING 2 0.0005
206 MECHANICAL VENTILATION 1 0.0005
207 HYPERTHERMIA 4 0.0005
208 HEPATIC MASS 1 0.0005
209 PANIC DISORDER 2 0.0005
210 HYPOVOLAEMIA 3 0.0005
211 PSYCHIATRIC DECOMPENSATION 1 0.0005
212 HYPOGEUSIA 1 0.0005
213 OCCULT BLOOD POSITIVE 1 0.0005
214 HYPERAEMIA 1 0.0005
215 DRUG INTERACTION 80 0.0005
216 SUICIDAL IDEATION 46 0.0005
217 PHARMACEUTICAL PRODUCT COMPLAINT 13 0.0005
218 MUSCLE TIGHTNESS 8 0.0005
219 PRE-EXISTING CONDITION IMPROVED 3 0.0005
220 FACIAL PALSY 1 0.0005
221 GASTROINTESTINAL ULCER 1 0.0005
222 RENAL COLIC 1 0.0004
223 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
224 BRAIN OPERATION 1 0.0004
225 AGITATION 32 0.0004
226 NEUROLOGICAL DECOMPENSATION 1 0.0004
227 FLAT AFFECT 1 0.0004
228 ROSACEA 2 0.0004
229 BILIRUBIN CONJUGATED INCREASED 1 0.0004
230 TARDIVE DYSKINESIA 12 0.0004
231 VOLVULUS 1 0.0004
232 MYOCLONUS 5 0.0004
233 PANIC REACTION 3 0.0004
234 ORAL INTAKE REDUCED 1 0.0004
235 MAJOR DEPRESSION 3 0.0004
236 BREATH ODOUR 1 0.0004
237 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
238 EYE OEDEMA 1 0.0004
239 DENTAL OPERATION 1 0.0004
240 DELIRIUM 14 0.0004
241 DEPRESSION 91 0.0004
242 CATHETER SITE HAEMORRHAGE 1 0.0004
243 VENTRICULAR HYPERTROPHY 1 0.0004
244 EXPOSURE VIA INGESTION 1 0.0004
245 EXCORIATION 1 0.0004
246 APPENDICITIS PERFORATED 1 0.0004
247 PARKINSON'S DISEASE 1 0.0004
248 SUBARACHNOID HAEMORRHAGE 4 0.0004
249 ILEOSTOMY 1 0.0004
250 EAR DISCOMFORT 4 0.0004
251 MENOPAUSE 1 0.0004
252 MEDICATION RESIDUE 1 0.0004
253 BLOOD CHLORIDE DECREASED 1 0.0004
254 TRISMUS 2 0.0004
255 STOMACH DISCOMFORT 2 0.0004
256 HERNIA REPAIR 1 0.0004
257 ANGER 13 0.0004
258 PANIC ATTACK 14 0.0004
259 URINE OUTPUT INCREASED 1 0.0004
260 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
261 ANAL FISSURE 2 0.0004
262 ANAESTHETIC COMPLICATION 1 0.0004
263 GASTROINTESTINAL INJURY 1 0.0004
264 POOR QUALITY SLEEP 8 0.0004
265 PRODUCT RESIDUE PRESENT 2 0.0004
266 ANORGASMIA 1 0.0004
267 SKIN WRINKLING 1 0.0004
268 TIC 2 0.0004
269 CLUMSINESS 1 0.0004
270 THYROID NEOPLASM 1 0.0004
271 ELECTRIC SHOCK SENSATION 1 0.0004
272 SKIN HYPERTROPHY 1 0.0004
273 HEART VALVE INCOMPETENCE 1 0.0003
274 EXERCISE TOLERANCE DECREASED 2 0.0003
275 MUSCLE TWITCHING 8 0.0003
276 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
277 HYPERVENTILATION 2 0.0003
278 SEXUAL DYSFUNCTION 4 0.0003
279 AGGRESSION 17 0.0003
280 ENERGY INCREASED 2 0.0003
281 CREPITATIONS 1 0.0003
282 GASTROINTESTINAL INFECTION 3 0.0003
283 SYMPTOM RECURRENCE 2 0.0003
284 BLOOD PRESSURE FLUCTUATION 8 0.0003
285 LOSS OF EMPLOYMENT 1 0.0003
286 BONE MARROW DISORDER 1 0.0003
287 RESTLESS LEGS SYNDROME 6 0.0003
288 HYPERHIDROSIS 42 0.0003
289 DRUG EFFECT INCREASED 1 0.0003
290 PHOTOPSIA 2 0.0003
291 THERAPEUTIC RESPONSE CHANGED 2 0.0003
292 MOOD SWINGS 10 0.0003
293 SOMNAMBULISM 2 0.0003
294 MANIA 5 0.0003
295 NEAR DEATH EXPERIENCE 1 0.0003
296 LYME DISEASE 1 0.0003
297 ANXIETY DISORDER 1 0.0003
298 HYPOTHERMIA 3 0.0003
299 BLOOD TESTOSTERONE DECREASED 2 0.0003
300 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
301 APLASIA PURE RED CELL 1 0.0003
302 DIFFICULTY IN WALKING 1 0.0003
303 ONYCHOCLASIS 2 0.0003
304 PARANOIA 5 0.0003
305 BLOOD CREATININE ABNORMAL 1 0.0003
306 MICTURITION DISORDER 1 0.0003
307 FORMICATION 2 0.0003
308 FEELING COLD 8 0.0003
309 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
310 INCONTINENCE 3 0.0003
311 JAUNDICE CHOLESTATIC 1 0.0003
312 GLOSSITIS 1 0.0003
313 FACIAL BONES FRACTURE 1 0.0003
314 COMPLETED SUICIDE 23 0.0003
315 SCLERODERMA 1 0.0003
316 RESTLESSNESS 10 0.0003
317 SEBORRHOEA 1 0.0003
318 PARADOXICAL DRUG REACTION 1 0.0003
319 DYSKINESIA 11 0.0003
320 NEURODERMATITIS 1 0.0003
321 THINKING ABNORMAL 5 0.0003
322 HAEMORRHAGE INTRACRANIAL 4 0.0003
323 SEDATION 7 0.0003
324 IMPULSIVE BEHAVIOUR 1 0.0003
325 DEPRESSED MOOD 14 0.0003
326 FACE INJURY 1 0.0003
327 TONGUE OEDEMA 1 0.0003
328 COMMUNICATION DISORDER 1 0.0003
329 AMNESIA 17 0.0003
330 DISSOCIATION 2 0.0003
331 BRAIN FOG 4 0.0003
332 AFFECTIVE DISORDER 2 0.0003
333 NAIL DISCOLOURATION 1 0.0003
334 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
335 ATAXIA 3 0.0003
336 DISORIENTATION 10 0.0003
337 MUSCLE RIGIDITY 3 0.0003
338 HYPERPHAGIA 1 0.0003
339 AZOTAEMIA 1 0.0003
340 IRRITABILITY 15 0.0002
341 CANDIDIASIS 1 0.0002
342 INTRACRANIAL ANEURYSM 1 0.0002
343 NERVOUSNESS 13 0.0002
344 GALLBLADDER OPERATION 1 0.0002
345 VITAMIN B12 DEFICIENCY 1 0.0002
346 SUBSTANCE ABUSE 2 0.0002
347 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
348 SELF-MEDICATION 1 0.0002
349 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
350 SUICIDAL BEHAVIOUR 1 0.0002
351 POLLAKIURIA 10 0.0002
352 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
353 DERMATITIS 5 0.0002
354 HAEMODIALYSIS 2 0.0002
355 SENSATION OF FOREIGN BODY 2 0.0002
356 LIP OEDEMA 1 0.0002
357 HYPERTENSION 50 0.0002
358 BUNDLE BRANCH BLOCK LEFT 1 0.0002
359 CIRCULATORY COLLAPSE 4 0.0002
360 UTERINE HAEMORRHAGE 1 0.0002
361 FACIAL PARALYSIS 2 0.0002
362 ALCOHOLISM 1 0.0002
363 INFUSION SITE PAIN 3 0.0002
364 HORDEOLUM 1 0.0002
365 CHAPPED LIPS 1 0.0002
366 INSOMNIA 61 0.0002
367 NAIL DISORDER 2 0.0002
368 NEUROTOXICITY 4 0.0002
369 BEDRIDDEN 3 0.0002
370 LIGAMENT RUPTURE 1 0.0002
371 BRADYCARDIA 12 0.0002
372 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
373 HEAD DISCOMFORT 4 0.0002
374 ILEUS PARALYTIC 1 0.0002
375 ANAL INCONTINENCE 2 0.0002
376 LUMBAR VERTEBRAL FRACTURE 1 0.0002
377 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
378 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
379 NERVE COMPRESSION 2 0.0002
380 HUNGER 3 0.0002
381 PERSONALITY CHANGE 2 0.0002
382 FEELING OF DESPAIR 1 0.0002
383 PERFORMANCE STATUS DECREASED 1 0.0002
384 PULSE ABSENT 1 0.0002
385 ANGINA PECTORIS 6 0.0002
386 BLOOD PRESSURE INCREASED 32 0.0002
387 IMPAIRED QUALITY OF LIFE 3 0.0002
388 HYPERTHYROIDISM 3 0.0002
389 GUILLAIN-BARRE SYNDROME 1 0.0002
390 PARKINSONISM 2 0.0002
391 HORMONE LEVEL ABNORMAL 1 0.0002
392 RENAL CELL CARCINOMA 1 0.0002
393 DISTURBANCE IN ATTENTION 11 0.0002
394 COELIAC DISEASE 2 0.0002
395 BREATH SOUNDS ABNORMAL 1 0.0002
396 DIABETIC NEUROPATHY 1 0.0002
397 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
398 MULTIPLE DRUG OVERDOSE 1 0.0002
399 TREATMENT NONCOMPLIANCE 11 0.0002
400 HYPERNATRAEMIA 1 0.0002
401 HYPOTONIA 2 0.0002
402 SALIVARY HYPERSECRETION 2 0.0002
403 BRAIN INJURY 2 0.0002
404 HEART RATE DECREASED 7 0.0002
405 HALLUCINATION 15 0.0002
406 SLEEP DISORDER 14 0.0002
407 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
408 DYSPHORIA 1 0.0002
409 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
410 TOXIC ENCEPHALOPATHY 1 0.0002
411 CORONARY ARTERIAL STENT INSERTION 1 0.0002
412 SLUGGISHNESS 2 0.0002
413 EUPHORIC MOOD 2 0.0002
414 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
415 TREMOR 32 0.0002
416 CRYING 7 0.0002
417 HEART RATE INCREASED 19 0.0002
418 MALABSORPTION 1 0.0002
419 TACHYCARDIA 17 0.0002
420 INTENTIONAL DRUG MISUSE 4 0.0002
421 MOUTH ULCERATION 4 0.0002
422 RENAL PAIN 2 0.0002
423 WEIGHT INCREASED 42 0.0002
424 COMPRESSION FRACTURE 1 0.0002
425 FEAR 5 0.0002
426 BIPOLAR DISORDER 2 0.0002
427 BACK INJURY 2 0.0002
428 JAW DISORDER 1 0.0002
429 DRUG WITHDRAWAL SYNDROME 16 0.0002
430 TOOTH FRACTURE 2 0.0002
431 GAIT INABILITY 6 0.0002
432 ANXIETY 51 0.0002
433 ORAL PAIN 4 0.0002
434 SKIN INFECTION 2 0.0002
435 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
436 PRODUCT AVAILABILITY ISSUE 4 0.0002
437 MICTURITION URGENCY 2 0.0002
438 HYPERSOMNIA 5 0.0002
439 MUSCLE SPASMS 32 0.0002
440 TINNITUS 8 0.0002
441 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
442 BALANCE DISORDER 15 0.0002
443 STRESS CARDIOMYOPATHY 1 0.0002
444 PARAESTHESIA 27 0.0002
445 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
446 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
447 COLD SWEAT 3 0.0002
448 URINE ODOUR ABNORMAL 1 0.0002
449 DECREASED INTEREST 1 0.0002
450 PSYCHOTIC DISORDER 5 0.0002
451 CATARACT OPERATION 1 0.0002
452 COMA 8 0.0002
453 PRODUCT PRESCRIBING ERROR 4 0.0002
454 CONFUSIONAL STATE 27 0.0002
455 APHASIA 5 0.0002
456 SUICIDE ATTEMPT 10 0.0002
457 DERMATITIS ACNEIFORM 1 0.0002
458 TENSION 1 0.0002
459 EPILEPSY 5 0.0002
460 CARDIOMEGALY 2 0.0002
461 SMALL INTESTINAL OBSTRUCTION 2 0.0002
462 INFUSION SITE EXTRAVASATION 1 0.0002
463 NERVOUS SYSTEM DISORDER 5 0.0002
464 NASAL DRYNESS 1 0.0002
465 PHOTOPHOBIA 3 0.0002
466 HOT FLUSH 12 0.0002
467 FEELING JITTERY 3 0.0002
468 INTENTIONAL OVERDOSE 10 0.0002
469 HAEMOGLOBIN ABNORMAL 1 0.0002
470 ANOREXIA 2 0.0002
471 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
472 INCOHERENT 1 0.0002
473 TENDON DISORDER 1 0.0002
474 BRADYPHRENIA 1 0.0002
475 ANHEDONIA 4 0.0002
476 PRODUCT FORMULATION ISSUE 1 0.0002
477 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
478 CORONAVIRUS INFECTION 1 0.0002
479 APPETITE DISORDER 1 0.0002
480 HAIR TEXTURE ABNORMAL 2 0.0001
481 INTENTIONAL SELF-INJURY 3 0.0001
482 POSTOPERATIVE WOUND INFECTION 1 0.0001
483 THROAT TIGHTNESS 4 0.0001
484 PRODUCT TASTE ABNORMAL 2 0.0001
485 BODY TEMPERATURE INCREASED 3 0.0001
486 MOOD ALTERED 4 0.0001
487 ECCHYMOSIS 1 0.0001
488 PALPITATIONS 17 0.0001
489 HAIR GROWTH ABNORMAL 1 0.0001
490 OVERDOSE 31 0.0001
491 HALLUCINATION, VISUAL 3 0.0001
492 DUODENAL ULCER 1 0.0001
493 HAND FRACTURE 1 0.0001
494 IMPAIRED WORK ABILITY 3 0.0001
495 PRODUCT SUPPLY ISSUE 1 0.0001
496 SOMNOLENCE 28 0.0001
497 TONGUE DISORDER 1 0.0001
498 DERMATITIS BULLOUS 1 0.0001
499 PRODUCT PRESCRIBING ISSUE 3 0.0001
500 DYSSTASIA 4 0.0001
501 ACUTE MYOCARDIAL INFARCTION 4 0.0001
502 CARDIOMYOPATHY 2 0.0001
503 FEELING DRUNK 1 0.0001
504 SPEECH DISORDER 7 0.0001
505 CHROMATURIA 3 0.0001
506 DYSARTHRIA 5 0.0001
507 HEART RATE IRREGULAR 3 0.0001
508 HEPATIC FAILURE 4 0.0001
509 PAROSMIA 1 0.0001
510 ILL-DEFINED DISORDER 8 0.0001
511 FOOD ALLERGY 1 0.0001
512 ATRIOVENTRICULAR BLOCK 1 0.0001
513 HAEMORRHAGIC STROKE 1 0.0001
514 PULMONARY HAEMORRHAGE 1 0.0001
515 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
516 ANAPHYLACTIC REACTION 7 0.0001
517 RENAL CYST 1 0.0001
518 NECK PAIN 7 0.0001
519 FEELING ABNORMAL 30 0.0001
520 MIOSIS 1 0.0001
521 MYASTHENIA GRAVIS 1 0.0001
522 FIBROMYALGIA 3 0.0001
523 DRY MOUTH 10 0.0001
524 MUSCULAR WEAKNESS 14 0.0001
525 DECUBITUS ULCER 1 0.0001
526 PRODUCT SUBSTITUTION ISSUE 7 0.0001
527 HAIR DISORDER 1 0.0001
528 EXTRAPYRAMIDAL DISORDER 3 0.0001
529 ACUTE CORONARY SYNDROME 1 0.0001
530 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
531 HEMIPLEGIA 1 0.0001
532 URINARY RETENTION 4 0.0001
533 ANURIA 1 0.0001
534 DIPLOPIA 3 0.0001
535 MENTAL DISORDER 5 0.0001
536 HEADACHE 72 0.0001
537 URINE OUTPUT DECREASED 1 0.0001
538 BLOOD CALCIUM INCREASED 1 0.0001
539 GASTRITIS 3 0.0001
540 GROIN PAIN 1 0.0001
541 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
542 WRONG DRUG ADMINISTERED 1 0.0001
543 ALOPECIA 22 0.0001
544 LOSS OF LIBIDO 1 0.0001
545 FREQUENT BOWEL MOVEMENTS 3 0.0001
546 OROPHARYNGEAL DISCOMFORT 1 0.0001
547 HYPOTENSION 22 0.0001
548 INCREASED TENDENCY TO BRUISE 1 0.0001
549 UROSEPSIS 1 0.0001
550 IRON DEFICIENCY ANAEMIA 1 0.0001
551 MENTAL STATUS CHANGES 3 0.0001
552 PRODUCT DISTRIBUTION ISSUE 1 0.0001
553 DEMENTIA 3 0.0001
554 NEPHROPATHY 1 0.0001
555 MIDDLE INSOMNIA 2 0.0001
556 HYPOAESTHESIA 16 0.0001
557 FLANK PAIN 1 0.0001
558 EYE PAIN 6 0.0001
559 LACERATION 1 0.0001
560 BLOOD SODIUM DECREASED 2 0.0001
561 POISONING DELIBERATE 1 0.0001
562 PRODUCT PACKAGING ISSUE 1 0.0001
563 GASTRIC ULCER 2 0.0001
564 SLEEP APNOEA SYNDROME 2 0.0001
565 POST PROCEDURAL COMPLICATION 2 0.0001
566 DRUG PRESCRIBING ERROR 2 0.0001
567 SINUS BRADYCARDIA 1 0.0001
568 HERNIA 2 0.0001
569 ERUCTATION 2 0.0001
570 MYOCARDIAL INFARCTION 18 0.0001
571 LIVER FUNCTION TEST ABNORMAL 3 0.0001
572 VITAMIN D DEFICIENCY 1 0.0001
573 HAEMORRHOIDS 2 0.0001
574 INFLAMMATORY BOWEL DISEASE 1 0.0001
575 VITREOUS FLOATERS 1 0.0001
576 KNEE OPERATION 1 0.0001
577 BODY TEMPERATURE DECREASED 1 0.0001
578 DISABILITY 2 0.0001
579 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
580 ABNORMAL BEHAVIOUR 4 0.0001
581 DIZZINESS 50 0.0001
582 MYALGIA 17 0.0001
583 FLUID RETENTION 5 0.0001
584 DRUG LEVEL DECREASED 1 0.0001
585 TOOTH ABSCESS 1 0.0001
586 FEELING HOT 6 0.0001
587 DRUG ADMINISTRATION ERROR 3 0.0001
588 TEMPERATURE INTOLERANCE 1 0.0001
589 VENTRICULAR EXTRASYSTOLES 1 0.0001
590 CONDITION AGGRAVATED 29 0.0001
591 FOLLICULITIS 1 0.0001
592 WITHDRAWAL SYNDROME 4 0.0001
593 INJECTION SITE DISCOMFORT 1 0.0001
594 VISION BLURRED 13 0.0001
595 CHILLS 11 0.0001
596 RETCHING 2 0.0001
597 BODY HEIGHT DECREASED 1 0.0001
598 CONTUSION 9 0.0001
599 IRRITABLE BOWEL SYNDROME 2 0.0001
600 PRURITUS GENERALISED 2 0.0001
601 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
602 BLOOD CREATININE INCREASED 6 0.0001
603 PSORIASIS 12 0.0001
604 ASPIRATION 1 0.0001
605 HAEMATOCHEZIA 5 0.0001
606 FOOT DEFORMITY 1 0.0001
607 NERVE INJURY 1 0.0001
608 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
609 RASH PAPULAR 2 0.0001
610 BLISTER 5 0.0001
611 FISTULA 1 0.0001
612 REBOUND EFFECT 1 0.0001
613 IMPAIRED DRIVING ABILITY 1 0.0001
614 SCAB 1 0.0001
615 CONVULSION 5 0.0001
616 MEMORY IMPAIRMENT 12 0.0001
617 NEOPLASM 1 0.0001
618 LETHARGY 5 0.0001
619 NIGHTMARE 3 0.0001
620 SEIZURE 10 0.0001
621 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
622 LOSS OF CONSCIOUSNESS 11 0.0001
623 DISEASE RECURRENCE 4 0.0001
624 MACULAR DEGENERATION 1 0.0001
625 WRIST FRACTURE 1 0.0001
626 BLOOD GLUCOSE DECREASED 4 0.0001
627 DRUG EFFECT INCOMPLETE 3 0.0001
628 MENTAL IMPAIRMENT 2 0.0001
629 SCHIZOPHRENIA 1 0.0001
630 OEDEMA PERIPHERAL 10 0.0001
631 ENCEPHALOPATHY 2 0.0001
632 SPINAL OPERATION 1 0.0001
633 BRONCHITIS 6 0.0001
634 PRODUCT QUALITY ISSUE 11 0.0001
635 HYPERCALCAEMIA 1 0.0001
636 GENERALISED OEDEMA 1 0.0001
637 ILEUS 1 0.0001
638 SYNCOPE 8 0.0001
639 MUSCULOSKELETAL STIFFNESS 7 0.0001
640 SECRETION DISCHARGE 1 0.0001
641 NAUSEA 63 0.0001
642 POISONING 1 0.0001
643 UNEVALUABLE EVENT 6 0.0001
644 MUSCLE ATROPHY 1 0.0001
645 ADVERSE DRUG REACTION 7 0.0001
646 ROTATOR CUFF SYNDROME 1 0.0001
647 INCORRECT PRODUCT STORAGE 1 0.0001
648 ADVERSE EVENT 7 0.0001
649 ORAL CANDIDIASIS 1 0.0001
650 CHEST PAIN 14 0.0001
651 BLOOD PRESSURE DECREASED 5 0.0001
652 DRUG DEPENDENCE 12 0.0001
653 LIMB INJURY 2 0.0001
654 IMPAIRED GASTRIC EMPTYING 1 0.0001
655 MIGRAINE 7 0.0001
656 ABNORMAL DREAMS 2 0.0001
657 DRUG INEFFECTIVE 95 0.0001
658 ROAD TRAFFIC ACCIDENT 3 0.0001
659 APHONIA 1 0.0001
660 OXYGEN SATURATION DECREASED 4 0.0001
661 BLOOD TEST ABNORMAL 1 0.0001
662 SEASONAL ALLERGY 1 0.0001
663 PAIN IN JAW 2 0.0001
664 DIALYSIS 1 0.0001
665 PARALYSIS 1 0.0001
666 PARAESTHESIA ORAL 1 0.0001
667 ASTHENIA 26 0.0001
668 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
669 RESPIRATORY FAILURE 5 0.0001
670 INTENTIONAL PRODUCT MISUSE 6 0.0001
671 MALAISE 30 0.0001
672 CHEST DISCOMFORT 7 0.0001
673 NASAL CONGESTION 4 0.0001
674 LABORATORY TEST ABNORMAL 2 0.0001
675 FALL 22 0.0001
676 ECONOMIC PROBLEM 1 0.0001
677 OSTEOPENIA 1 0.0001
678 INSURANCE ISSUE 1 0.0001
679 HYPOKALAEMIA 3 0.0001
680 ARTHRALGIA 27 0.0001
681 THYROID DISORDER 1 0.0001
682 ANKLE FRACTURE 1 0.0001
683 WEIGHT DECREASED 18 0.0001
684 DELUSION 1 0.0001
685 BASAL CELL CARCINOMA 1 0.0001
686 DYSPNOEA 36 0.0001
687 CYANOSIS 1 0.0001
688 ARRHYTHMIA 3 0.0001
689 HALLUCINATION, AUDITORY 1 0.0001
690 ULCER 1 0.0001
691 SCIATICA 1 0.0001
692 SENSORY DISTURBANCE 1 0.0001
693 HIP FRACTURE 2 0.0001
694 RHINORRHOEA 4 0.0001
695 HYPOGLYCAEMIA 3 0.0001
696 BLOOD POTASSIUM INCREASED 1 0.0001
697 CARDIAC ARREST 5 0.0001
698 DRY EYE 3 0.0001
699 COAGULOPATHY 1 0.0001
700 FACE OEDEMA 1 0.0001
701 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
702 GASTRIC DISORDER 2 0.0001
703 MULTI-ORGAN FAILURE 1 0.0001
704 FATIGUE 45 0.0001
705 ECZEMA 3 0.0001
706 RASH MACULAR 2 0.0001
707 LYMPHOCYTE COUNT DECREASED 1 0.0001
708 BACK PAIN 13 0.0001
709 CEREBRAL HAEMORRHAGE 2 0.0001
710 SYNOVITIS 1 0.0001
711 GASTROENTERITIS VIRAL 1 0.0001
712 RASH PRURITIC 3 0.0001
713 OEDEMA 3 0.0001
714 LEUKOCYTOSIS 1 0.0001
715 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
716 PELVIC PAIN 1 0.0001
717 HYPERGLYCAEMIA 2 0.0001
718 END STAGE RENAL DISEASE 1 0.0001
719 CONJUNCTIVITIS 1 0.0001
720 BACTERIAL INFECTION 1 0.0001
721 ABDOMINAL PAIN UPPER 11 0.0001
722 HYPONATRAEMIA 3 0.0001
723 CEREBROVASCULAR ACCIDENT 9 0.0001
724 INTESTINAL OBSTRUCTION 2 0.0001
725 FRACTURE 1 0.0001
726 DEHYDRATION 7 0.0001
727 DYSPHONIA 3 0.0001
728 CHOKING 1 0.0001
729 BONE PAIN 3 0.0001
730 KIDNEY INFECTION 1 0.0001
731 ARTHRITIS 4 0.0001
732 CONSTIPATION 11 0.0001
733 CATARACT 3 0.0001
734 UPPER LIMB FRACTURE 1 0.0001
735 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
736 DISCOMFORT 3 0.0000
737 VOMITING 23 0.0000
738 ERYTHEMA 10 0.0000
739 RIB FRACTURE 1 0.0000
740 PERITONITIS 1 0.0000
741 TOOTH LOSS 1 0.0000
742 PULMONARY HYPERTENSION 1 0.0000
743 RENAL IMPAIRMENT 4 0.0000
744 KNEE ARTHROPLASTY 1 0.0000
745 OSTEOARTHRITIS 2 0.0000
746 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
747 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
748 APPLICATION SITE PAIN 1 0.0000
749 RENAL FAILURE 6 0.0000
750 STEVENS-JOHNSON SYNDROME 1 0.0000
751 TOOTH DISORDER 1 0.0000
752 NEPHROLITHIASIS 2 0.0000
753 PNEUMONIA 14 0.0000
754 DECREASED APPETITE 10 0.0000
755 RENAL DISORDER 2 0.0000
756 COGNITIVE DISORDER 2 0.0000
757 OCULAR HYPERAEMIA 2 0.0000
758 NEUROPATHY PERIPHERAL 4 0.0000
759 PRODUCTIVE COUGH 2 0.0000
760 GAIT DISTURBANCE 8 0.0000
761 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
762 TOXICITY TO VARIOUS AGENTS 7 0.0000
763 NEURALGIA 1 0.0000
764 LIVER INJURY 1 0.0000
765 PAIN IN EXTREMITY 12 0.0000
766 DYSPEPSIA 4 0.0000
767 ABASIA 1 0.0000
768 DYSGEUSIA 3 0.0000
769 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
770 AGEUSIA 1 0.0000
771 ABDOMINAL PAIN LOWER 1 0.0000
772 CARDIOVASCULAR DISORDER 1 0.0000
773 DIABETES MELLITUS 3 0.0000
774 HYPOPHAGIA 1 0.0000
775 SINUSITIS 4 0.0000
776 THERAPY CESSATION 2 0.0000
777 ERECTILE DYSFUNCTION 1 0.0000
778 DRUG RESISTANCE 1 0.0000
779 ANAPHYLACTIC SHOCK 1 0.0000
780 UNRESPONSIVE TO STIMULI 1 0.0000
781 ABDOMINAL PAIN 9 0.0000
782 SKIN ULCER 1 0.0000
783 DEAFNESS 1 0.0000
784 MUCOSAL INFLAMMATION 1 0.0000
785 APPLICATION SITE ERYTHEMA 1 0.0000
786 JOINT STIFFNESS 1 0.0000
787 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
788 DRUG EFFECT DECREASED 2 0.0000
789 NEUTROPENIA 5 0.0000
790 OFF LABEL USE 32 0.0000
791 SKIN LESION 1 0.0000
792 RESPIRATORY DISTRESS 1 0.0000
793 TREATMENT FAILURE 3 0.0000
794 DIVERTICULITIS 1 0.0000
795 DRUG ABUSE 3 0.0000
796 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
797 URTICARIA 6 0.0000
798 THROMBOCYTOPENIA 4 0.0000
799 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
800 INTENTIONAL DOSE OMISSION 1 0.0000
801 RED BLOOD CELL COUNT DECREASED 1 0.0000
802 HERPES ZOSTER 2 0.0000
803 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
804 URINARY INCONTINENCE 1 0.0000
805 RESPIRATORY DISORDER 1 0.0000
806 PREMATURE BABY 1 0.0000
807 EMOTIONAL DISTRESS 4 0.0000
808 CORONARY ARTERY DISEASE 1 0.0000
809 THERAPEUTIC RESPONSE DECREASED 2 0.0000
810 VERTIGO 2 0.0000
811 PERIPHERAL SWELLING 5 0.0000
812 EMOTIONAL DISORDER 1 0.0000
813 OROPHARYNGEAL PAIN 3 0.0000
814 LIMB DISCOMFORT 1 0.0000
815 VISUAL IMPAIRMENT 4 0.0000
816 SWELLING 3 0.0000
817 SWOLLEN TONGUE 1 0.0000
818 PYREXIA 11 0.0000
819 DYSPHAGIA 3 0.0000
820 HYPOTHYROIDISM 1 0.0000
821 METABOLIC ACIDOSIS 1 0.0000
822 NIGHT SWEATS 1 0.0000
823 PAIN 19 0.0000
824 LACTIC ACIDOSIS 1 0.0000
825 SWELLING FACE 2 0.0000
826 PRODUCT DOSE OMISSION 2 0.0000
827 IMPAIRED HEALING 1 0.0000
828 EYE DISORDER 1 0.0000
829 DRUG DOSE OMISSION 5 0.0000
830 VISUAL ACUITY REDUCED 1 0.0000
831 VIRAL INFECTION 1 0.0000
832 FUNGAL INFECTION 1 0.0000
833 SKIN DISORDER 1 0.0000
834 EYE PRURITUS 1 0.0000
835 TYPE 2 DIABETES MELLITUS 1 0.0000
836 DIARRHOEA 19 0.0000
837 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
838 HEPATIC ENZYME INCREASED 2 0.0000
839 HAEMATURIA 1 0.0000
840 ILLNESS 3 0.0000
841 DEVICE USE ERROR 1 0.0000
842 NEOPLASM PROGRESSION 1 0.0000
843 ABDOMINAL DISTENSION 3 0.0000
844 BURNING SENSATION 2 0.0000
845 DEVICE MALFUNCTION 2 0.0000
846 INJURY 2 0.0000
847 HYPOXIA 1 0.0000
848 LYMPHADENOPATHY 1 0.0000
849 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
850 MOBILITY DECREASED 2 0.0000
851 C-REACTIVE PROTEIN INCREASED 1 0.0000
852 ACCIDENTAL OVERDOSE 1 0.0000
853 EYE SWELLING 1 0.0000
854 DYSPNOEA EXERTIONAL 1 0.0000
855 COLITIS 1 0.0000
856 CHRONIC KIDNEY DISEASE 2 0.0000
857 ACUTE KIDNEY INJURY 4 0.0000
858 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
859 JOINT SWELLING 3 0.0000
860 EXTRA DOSE ADMINISTERED 1 0.0000
861 DEVICE BREAKAGE 1 0.0000
862 BLINDNESS 1 0.0000
863 INFLUENZA LIKE ILLNESS 2 0.0000
864 RHABDOMYOLYSIS 1 0.0000
865 ABDOMINAL DISCOMFORT 4 0.0000
866 URINARY TRACT INFECTION 4 0.0000
867 VAGINAL HAEMORRHAGE 1 0.0000
868 DEVICE DISLOCATION 1 0.0000
869 RASH 10 0.0000
870 PRODUCT STORAGE ERROR 2 0.0000
871 ANGIOEDEMA 1 0.0000
872 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
873 COLITIS ULCERATIVE 1 0.0000
874 PULMONARY OEDEMA 1 0.0000
875 GASTROINTESTINAL DISORDER 2 0.0000
876 SKIN IRRITATION 1 0.0000
877 SKIN DISCOLOURATION 1 0.0000
878 NASOPHARYNGITIS 4 0.0000
879 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
880 BREAST CANCER 2 0.0000
881 BLOOD CHOLESTEROL INCREASED 1 0.0000
882 COUGH 6 0.0000
883 CARDIAC DISORDER 2 0.0000
884 RASH ERYTHEMATOUS 1 0.0000
885 INTERSTITIAL LUNG DISEASE 1 0.0000
886 PRODUCT DOSE OMISSION ISSUE 6 0.0000
887 LEUKOPENIA 1 0.0000
888 CELLULITIS 1 0.0000
889 FLUSHING 2 0.0000
890 HAEMOGLOBIN DECREASED 2 0.0000
891 INFLAMMATION 1 0.0000
892 HAEMORRHAGE 2 0.0000
893 PLATELET COUNT DECREASED 2 0.0000
894 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
895 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
896 ARTHROPATHY 1 0.0000
897 MEDICATION ERROR 1 0.0000
898 SEPSIS 2 0.0000
899 ASTHMA 2 0.0000
900 FLATULENCE 1 0.0000
901 COVID-19 3 0.0000
902 WHEEZING 1 0.0000
903 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
904 HYPERSENSITIVITY 3 0.0000
905 PRODUCT USE ISSUE 3 0.0000
906 BLOOD GLUCOSE INCREASED 3 0.0000
907 DEVICE EXPULSION 1 0.0000
908 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
909 THERAPY INTERRUPTED 1 0.0000
910 UNDERDOSE 1 0.0000
911 EPISTAXIS 1 0.0000
912 ACNE 1 0.0000
913 INCORRECT DOSE ADMINISTERED 3 0.0000
914 PRURITUS 5 0.0000
915 CARDIAC FAILURE 1 0.0000
916 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
917 SKIN EXFOLIATION 1 0.0000
918 NO ADVERSE EVENT 2 0.0000
919 PULMONARY EMBOLISM 1 0.0000
920 ANAEMIA 2 0.0000
921 DRUG INTOLERANCE 1 0.0000
922 ATRIAL FIBRILLATION 1 0.0000
923 RHEUMATOID ARTHRITIS 1 0.0000
924 DISEASE PROGRESSION 1 0.0000
925 DEATH 3 0.0000